Infectious diseases syndromes are common in primary care practices. However, staying current with relevant literature that may influence appropriate evaluation and treatment of patients with these syndromes can be difficult, given the volumes of applicable articles and diversity of journals publishing these reports. This session will present some common infectious disease scenarios and provide crucial literature updates. You will learn about how responding to histories of penicillin allergy may result in adverse patient outcomes, the proper timing of influenza vaccination, the influence of substance abuse on risk medication adherence and infectious diseases risk, the appropriate evaluation of patients with suspected cellulitis syndromes, and the role of preoperative urine screening.

Common sleep myths pervade both the community and the medical world. In this session, the faculty will address the science behind them and present methods to manage these situations preemptively. The talk will cover several common sleep-related complaints that present to primary care: insomnia, daytime sleepiness, and sleep apnea. You will also walk away with information about more unusual conditions—such as restless leg syndrome and excessive sleepiness—and how to use questionnaires to diagnose them.

By determining the target of inflammation in the joint and the distribution of affected joints, a clinician can distinguish among non-inflammatory arthritis (osteoarthritis), other non-inflammatory rheumatic conditions (like fibromyalgia), and inflammatory conditions such as inflammatory synovitis (rheumatoid arthritis) and inflammatory enthesitis (ankylosing spondylitis, psoriatic arthritis).

I will discuss the clinical evaluation of a patient from initial finding of an abnormal chest imaging to diagnosis of lung cancer. CT scans of the chest often have abnormalities where some require urgent work up and others require later CT scans or even no follow up driven by the characteristics of the abnormalities and patient’s risk analysis. Work up of the Chest CT abnormalities differs based on its location and associated findings in mediastinal nodes and/or extrathoracic findings. Based on this analysis, different techniques of biopsy will apply often directed by the findings of a PT CT scan. The work up algorithm is designed to ensure that diagnosis is obtained using a strategy focused on determining a cancer’s stage and diagnosis using a single biopsy. Each biopsy method has unique attributes that pertain both to yield and complication rates that need to factor into the decision on how to biopsy. Finally, obtaining tissue diagnosis now requires molecular analysis of the tumor to dictate treatment decisions. Issues on appropriately obtaining adequate tissue samples are discussed.

This session will review the indications, risks, and benefits of commonly recommended vaccines. Most of the session will focus on communication strategies to enhance trust in the context of working with vaccine-resistant or vaccine-hesitant patients and parents. You will have the opportunity to engage with motivational interviewing strategies that you can use in your practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020, and they are subject to change as new information is published.

This talk will cover recent clinical trials presented at the ADA in 2019 that have an impact on the management of diabetes, such as cardiovascular outcomes trials and the first oral GLP-1 RA phase 3 data. The faculty will take you through the latest guidelines from the ADA regarding the management of type 2 diabetes and describe how recent clinical trial data has been integrated in to these guidelines. After this meeting review, you will be equipped to manage type 2 diabetes based on these guidelines. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020, and they are subject to change as new information is published.

e-Cigarettes were 1st introduced to the US market in 2007, essentially to help smokers stop smoking tobacco-based cigarettes. There is some evidence that, for some adults, it may be beneficial to assist with smoking cessation. However, the use of e-Cigarettes and vaping (referred to as ENDS – electronic nicotine delivery systems), has increased significantly, specifically in the US teen population. The FDA and AAP have addressed the concerns surrounding e-Cigarettes and vaping in both regulations and policy statements. Join us as we discuss the latest evidence, potential benefits, and public health concerns regarding e-Cigarettes and vaping. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020 and they are subject to change as new information is published.

This talk will give a historical perspective of psychiatry and how its course of change has impacted primary care clinicians. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020, and they are subject to change as new information is published.

This lecture will discuss the underappreciated health benefits of exercise on a range of medical problems. It provides clinicians with the information they need to make the decision to emphasize exercise as an important part of preventive health in the office and a practical, effective approach to advising patients in the office. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020, and they are subject to change as new information is published.

Get your questions answered by expert faculty in Nephrology. You ask: we listen. You will learn practical solutions to common clinical challenges and tips to apply the latest knowledge in practice.

This talk will review issues surrounding C. difficile and transmission prevention. After a thorough discussion on antibiotic therapy, the speaker will evaluate the increased use of fecal microbiota transplant (FMT) in recurrent C. difficile treatment and expand on potential extended applications of the procedure.